drugset / Trial / NCT00126412
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
NaSingle-groupOpen-labelDiagnostic
Summary
The study is designed to study the effectiveness of 123I-mIBG as a diagnostic imaging agent in evaluating patients with known or suspected neuroblastoma or phaeochromocytoma.
Timeline
- Start
- 2005-08-02
- Primary completion
- 2006-09-27
- Completion
- 2006-09-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 123I-mIBG | Diagnostic / imaging agent | 80 mbq | Intravenous |
| Subject | 123I-mIBG | Diagnostic / imaging agent | 370 mbq | Intravenous |